| Centers | ||
| UCSC Chemical Screening Center | FDA Oncology Center of Excellence Project Catalyst | Saint Louis University Institute for Drug and Biotherapeutic Innovation (IDBI) | 
| We are a shared research facility dedicated to improving human health by finding therapeutic agents against a wide variety of diseases, dedicated to advancing scientific knowledge and technologies, and dedicated to education of the next generation of... | Providing a regulatory platform to connect scientific knowledge, creative insight, and medical professionals to foster early-stage product innovation | 
 The IDBI is a decentralized, collaborative institute whose mission is to promote the translation of research projects at Saint Louis University through drug discovery and pre-clinical development. The IDBI achieves this through four main... | 
| Partnerships | Events | Jobs | 
| Astra Zeneca and Broad Institute to Co-develop Antiviral and Antibacterial DrugsBroad Institute and Astrza Zeneca have entered into a two year collaboration agreement to co-develop antiviral and antibacterial drugs. Screening and target hit to lead chemistry will take place at Broad while Astra Zeneca will be responsible for... View all Yale to Partner with Gilead to Further Cancer ResearchYale and Gilead have entered into a multi-year research collaboration to develop new treatments against cancer. Gilead will provide $40million in funding for research and other infrastructure support for the initial four years. The agreement can... View all Sanofi to Collaborate with UCSF to Develop New Drugs to Treat DiabetesUniversity of California, San Francisco (UCSF) has entered into a broad collaboration agreement with Sanofi to develop new therapies to treat Diabetes (Type 1 & 2). Scientists with deep biology expertise at Sanofi will be partnering with... View all | No EVENTS for listing | No Job Posts | 



 
								 
								 
								 
						 		
								 
								
								 
								
								 
								
								 
								
								 
								
								 
								
								